Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-03-11

Clinical Trial Update: A Study of the Effect of LY2216684 on Lorazepam [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating the effect of LY2216684 on lorazepam in healthy or affected individuals; completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LY2216684
  • Lorazepam (Lorazepam)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Major Depressive Disorder | Phase 1 | Status: COMPLETED | Results posted: 2019-03-11